The voice of blood establishments in Europe
A core activity of EBA is representing blood establishments in our dialogue with legislators and policy-makers, contributing to Europe’s progress towards an even safer and more sustainable supply of all blood components.
EBA is recognised by European and national institutions as the leading voice of public and not-for-profit blood establishments, a reliable source of expertise and evidence-based information.
Topics we work on:
Blood is a highly regulated area in Europe, being singled out in the European Treaties as meriting minimum EU-wide standards of quality and safety. EBA has a dedicated Working Group whose members monitor European legislation on blood and formulate EBA’s positions and advice for adoption by the EBA Board. Through its advocacy, EBA ensures that European lawmakers are aware of the impact of proposed EU legislation on blood safety and supply and that they can access the expertise of blood establishments in finding the best regulatory solutions.
EBA is currently working on several pieces of legislation including:
The experience and expertise within EBA makes it a regular contributor to the work of European policy-making institutions, such as the European Commission, the Council of Europe’s EDQM, the European Centre for Disease Prevention and Control (ECDC) or the European Medicines Agency (EMA).
EBA also cooperates regularly with a wide range of partner organisations representing donors, patients, health professional groups and many other sectoral and scientific communities.
EBA is a member of the Common Representation of Substance of Human Origin (CoRe SoHO), the consortium of professional scientific associations in the field of SoHO and that also includes the European Association of Tissue and Cell Banks (EATCB), the European Eye Bank Association (EEBA) and the European Society for Blood and Marrow Transplantation (EBMT).